|
|
|
|
|
|
|
27.06.25 - 11:45
|
Philips Buy (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Philips auf "Buy" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen festgestellt, schrieb Graham Doyle in einer am Freitag vorliegenden ......
|
|
|
26.06.25 - 08:24
|
Philips Overweight (DPA-AFX)
|
|
|
LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Philips von 28,00 auf 27,50 Euro gesenkt, aber die Einstufung auf "Overweight" belassen. Das zweite Quartal dürfte etwas besser gewesen sein als der Jahresauftakt, ......
|
|
|
24.06.25 - 08:39
|
Philips Neutral (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Philips mit einem Kursziel von 15,30 Euro auf "Neutral" belassen. Die Ausgangslage sei gegenüber dem ersten Quartal unverändert, schrieb David Adlington in seinem am Dienstag vorliegenden ......
|
|
|
|
|
20.06.25 - 10:51
|
Philips Buy (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Philips mit einem Kursziel von 26 Euro auf "Buy" belassen. Die Niederländer seien das Unternehmen im europäischen Medtech-Bereich, bei denen sich die Investoren besonders einig ......
|
|
|
|
|
|
|
|
|
05.06.25 - 15:03
|
PaceMate® Names JR Finkelmeier CEO As It Sets Its Sights on Large-Scale Expansion (Business Wire)
|
|
|
Founding CEO Tripp Higgins To Become Chairman of the Board of Directors, Supporting the Leadership Transition As Finkelmeier Puts Operational Structure in Place to Meet Growing DemandSARASOTA, Fla.--(BUSINESS WIRE)--PaceMate, the cardiac remote monitoring platform that leading healthcare providers trust, today announced the appointment of JR Finkelmeier as Chief Executive Officer (CEO). Finkelmeier joined PaceMate as Chief Commercial Officer in 2024, after years leading Philips' multi-hundred-million-dollar ambulatory monitoring division. As CEO of PaceMate, he will lead the company through operational transformation in support of plans for significant commercial expansion. Finkelmeier succeeds founding CEO Tripp Higgins, who will become the Chairman of the Board of Directors.
Since its founding 10 years ago, PaceMate has achieved widespread adoption by healthcare providers like Duke Health, Advocate Health and many others. In 2024, PaceMate acquired Medtronic's PaceArt Optima™ system, adding nearly 1...
|
|
|
05.06.25 - 12:03
|
Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people (GlobeNewswire EN)
|
|
|
Amsterdam, the Netherlands – Marking its tenth anniversary, Philips Foundation today released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around the world – a significant increase from 28 million the year before. This progress was driven by 22 new initiatives and five new early-stage capital impact investments that expanded Philips Foundation's reach, channeling Philips' health technology expertise to help address the growing burden of non-communicable diseases and maternal health challenges, predominantly at the primary care level in underserved communities. “Today, half of the global population still does not have access to healthcare. Innovation and new digital technologies, combined with an ecosystem of partners, can improve health outcomes and make progress towards a future where quality healthcare is within reach for everyone,” said Marnix van Ginneken, Chair of the Board of the Philips...
|
|
|
|
|
|
|
|
|
|
|
|
|
26.05.25 - 14:30
|
Philips Buy (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Philips auf "Buy" belassen. In der MedTech-Branche wäre Carl Zeiss Meditec gemeinsam mit Siemens Healthineers besonders von Trumps 50-Prozent-Zöllen gegen die EU betroffen, ......
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
